T1	Participants 156 241	better sedation than alternative agents in patients who require long-term ventilation
T2	Participants 363 480	patients predicted to require artificial ventilation for at least 48 h were entered into a randomised crossover study
T3	Participants 556 625	no significant differences between the two agents in either end-point
